Skip Navigation


JAC Advance Access originally published online on September 13, 2005
Journal of Antimicrobial Chemotherapy 2005 56(5):965-967; doi:10.1093/jac/dki334
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/5/965    most recent
dki334v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kim, J. M.
Right arrow Articles by Song, I. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. M.
Right arrow Articles by Song, I. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients

Jung Mogg Kim1,*, Joo Sung Kim2, Nayoung Kim2, Hyun Chae Jung2 and In Sung Song2

1 Department of Microbiology and Institute of Biomedical Science, Hanyang University College of Medicine, Seoul, 2 Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea

Received 9 July 2005; returned 7 August 2005; revised 22 August 2005; accepted 22 August 2005

* Correspondence address. Department of Microbiology, Hanyang University College of Medicine, 17 Haengdang-dong, Sungdong-gu, Seoul 133–791, Korea. Tel: +82-2-2220-0645; Fax: +82-2-2282-0645; E-mail: jungmogg{at}hanyang.ac.kr

Objectives: The aim of this study was to assess the prevalence rate of primary fluoroquinolone resistance in Helicobacter pylori isolates from Korean patients over the past 16 years.

Methods: One hundred and thirty-five strains of H. pylori (34 strains in 1987, 36 in 1994 and 65 in 2003) were isolated from antral gastric mucosal biopsy specimens. The determination of MICs for the H. pylori isolates of ciprofloxacin, levofloxacin and moxifloxacin was examined by using the serial 2-fold agar dilution method. DNA sequences of the gyrA gene in fluoroquinolone-resistant strains were determined.

Results: The distribution of fluoroquinolone MICs (ciprofloxacin, levofloxacin and moxifloxacin) shifted to higher concentrations during 1987–2003. All of the levofloxacin- or moxifloxacin-resistant strains were resistant to ciprofloxacin. Sequence analysis in fluoroquinolone-resistant strains showed point mutation of the gyrA gene at A272G and G271A, indicating mutations of the codon Asp-91 in the fluoroquinolone-resistance-determining region of the DNA gyrase.

Conclusions: These results suggest that resistance to fluoroquinolones has been increasing in the Korean population and the resistance is most likely mediated through point mutation in gyrA.

Keywords: gyrA , mutation , QRDR , resistance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
E. Glocker, H.-P. Stueger, and M. Kist
Quinolone Resistance in Helicobacter pylori Isolates in Germany
Antimicrob. Agents Chemother., January 1, 2007; 51(1): 346 - 349.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.